These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 30192978)

  • 1. Excessive daytime sleepiness and napping in cognitively normal adults: associations with subsequent amyloid deposition measured by PiB PET.
    Spira AP; An Y; Wu MN; Owusu JT; Simonsick EM; Bilgel M; Ferrucci L; Wong DF; Resnick SM
    Sleep; 2018 Oct; 41(10):. PubMed ID: 30192978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Excessive Daytime Sleepiness With Longitudinal β-Amyloid Accumulation in Elderly Persons Without Dementia.
    Carvalho DZ; St Louis EK; Knopman DS; Boeve BF; Lowe VJ; Roberts RO; Mielke MM; Przybelski SA; Machulda MM; Petersen RC; Jack CR; Vemuri P
    JAMA Neurol; 2018 Jun; 75(6):672-680. PubMed ID: 29532057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal patterns of β-amyloid deposition in nondemented older adults.
    Sojkova J; Zhou Y; An Y; Kraut MA; Ferrucci L; Wong DF; Resnick SM
    Arch Neurol; 2011 May; 68(5):644-9. PubMed ID: 21555640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depressive and anxiety symptoms and cortical amyloid deposition among cognitively normal elderly persons: the Mayo Clinic Study of Aging.
    Krell-Roesch J; Lowe VJ; Neureiter J; Pink A; Roberts RO; Mielke MM; Vemuri P; Stokin GB; Christianson TJ; Jack CR; Knopman DS; Boeve BF; Kremers WK; Petersen RC; Geda YE
    Int Psychogeriatr; 2018 Feb; 30(2):245-251. PubMed ID: 29198244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of β-Amyloid Burden With Sleep Dysfunction and Cognitive Impairment in Elderly Individuals With Cognitive Disorders.
    You JC; Jones E; Cross DE; Lyon AC; Kang H; Newberg AB; Lippa CF
    JAMA Netw Open; 2019 Oct; 2(10):e1913383. PubMed ID: 31617927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease.
    Doré V; Villemagne VL; Bourgeat P; Fripp J; Acosta O; Chetélat G; Zhou L; Martins R; Ellis KA; Masters CL; Ames D; Salvado O; Rowe CC
    JAMA Neurol; 2013 Jul; 70(7):903-11. PubMed ID: 23712469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Syndrome and Amyloid Accumulation in the Aging Brain.
    Gomez G; Beason-Held LL; Bilgel M; An Y; Wong DF; Studenski S; Ferrucci L; Resnick SM
    J Alzheimers Dis; 2018; 65(2):629-639. PubMed ID: 30103324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.
    Leinonen V; Alafuzoff I; Aalto S; Suotunen T; Savolainen S; Någren K; Tapiola T; Pirttilä T; Rinne J; Jääskeläinen JE; Soininen H; Rinne JO
    Arch Neurol; 2008 Oct; 65(10):1304-9. PubMed ID: 18695050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Short and Long Sleep Duration With Amyloid-β Burden and Cognition in Aging.
    Winer JR; Deters KD; Kennedy G; Jin M; Goldstein-Piekarski A; Poston KL; Mormino EC
    JAMA Neurol; 2021 Oct; 78(10):1187-1196. PubMed ID: 34459862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-reported sleep and β-amyloid deposition in community-dwelling older adults.
    Spira AP; Gamaldo AA; An Y; Wu MN; Simonsick EM; Bilgel M; Zhou Y; Wong DF; Ferrucci L; Resnick SM
    JAMA Neurol; 2013 Dec; 70(12):1537-43. PubMed ID: 24145859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Sleep-Disordered Breathing With Alzheimer Disease Biomarkers in Community-Dwelling Older Adults: A Secondary Analysis of a Randomized Clinical Trial.
    André C; Rehel S; Kuhn E; Landeau B; Moulinet I; Touron E; Ourry V; Le Du G; Mézenge F; Tomadesso C; de Flores R; Bejanin A; Sherif S; Delcroix N; Manrique A; Abbas A; Marchant NL; Lutz A; Klimecki OM; Collette F; Arenaza-Urquijo EM; Poisnel G; Vivien D; Bertran F; de la Sayette V; Chételat G; Rauchs G;
    JAMA Neurol; 2020 Jun; 77(6):716-724. PubMed ID: 32202593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts.
    Resnick SM; Bilgel M; Moghekar A; An Y; Cai Q; Wang MC; Thambisetty M; Prince JL; Zhou Y; Soldan A; Wong DF; O'Brien RJ; Ferrucci L; Albert MS
    Neurobiol Aging; 2015 Aug; 36(8):2333-9. PubMed ID: 26004017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High amyloid-β deposition related to depressive symptoms in older individuals with normal cognition: a pilot study.
    Yasuno F; Kazui H; Morita N; Kajimoto K; Ihara M; Taguchi A; Yamamoto A; Matsuoka K; Kosaka J; Kudo T; Iida H; Kishimoto T; Nagatsuka K
    Int J Geriatr Psychiatry; 2016 Aug; 31(8):920-8. PubMed ID: 26766490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating a novel 24-hour rest/activity rhythm marker of preclinical β-amyloid deposition.
    Spira AP; Liu F; Zipunnikov V; Bilgel M; Rabinowitz JA; An Y; Di J; Bai J; Wanigatunga SK; Wu MN; Lucey BP; Schrack JA; Wanigatunga AA; Rosenberg PB; Simonsick EM; Walker KA; Ferrucci L; Resnick SM
    Sleep; 2024 May; 47(5):. PubMed ID: 38381532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
    Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
    Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Engler H; Forsberg A; Almkvist O; Blomquist G; Larsson E; Savitcheva I; Wall A; Ringheim A; Långström B; Nordberg A
    Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conscientiousness is associated with less amyloid deposition in cognitively normal aging.
    Yoon B; Baker SL; Korman D; Tennant VR; Harrison TM; Landau S; Jagust WJ
    Psychol Aging; 2020 Nov; 35(7):993-999. PubMed ID: 33166168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging beta-amyloid burden in aging and dementia.
    Rowe CC; Ng S; Ackermann U; Gong SJ; Pike K; Savage G; Cowie TF; Dickinson KL; Maruff P; Darby D; Smith C; Woodward M; Merory J; Tochon-Danguy H; O'Keefe G; Klunk WE; Mathis CA; Price JC; Masters CL; Villemagne VL
    Neurology; 2007 May; 68(20):1718-25. PubMed ID: 17502554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition.
    Park JC; Han SH; Cho HJ; Byun MS; Yi D; Choe YM; Kang S; Jung ES; Won SJ; Kim EH; Kim YK; Lee DY; Mook-Jung I
    Alzheimers Res Ther; 2017 Mar; 9(1):20. PubMed ID: 28330509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.